Data compiled by Redley Lamar · ChainSifter Intelligence
4Suppliers
2Customers
3Debt Items
0Related Chains
Source-Backed Evidence Depth
Enveric Biosciences, Inc. (ENVB) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
19Total relationships
3Distinct source URLs
19High confidence
0.922Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Enveric Biosciences, Inc. Suppliers
Ticker
Name
Confidence
Evidence
ARIES-SCIENCE-AND-TECHNOLOGY-LLC
ARIES-SCIENCE-AND-TECHNOLOGY-LLC
92%
On July 10, 2024, Akos entered into an Exclusive License Agreement with Aries Science and Technology, LLC, an Ohio limited liability company ('Aries'), pursuant to which Akos granted Aries a license …
DIVERSE-BIOTECH-INC
DIVERSE-BIOTECH-INC
90%
A portfolio of cannabinoid conjugate technology licensed in from Diverse Biotech, Inc., is sublicensed to Restoration Biologics, LLC as part of the licenses to Restoration Biologics, LLC
TEOTEC-PHARMA
TEOTEC-PHARMA
85%
Subsequent to the execution of the License Agreement, Aries transferred the licensed rights to its wholly owned subsidiary, Teotec Pharma.
RESTORATION-BIOLOGICS-LLC
RESTORATION-BIOLOGICS-LLC
80%
On February 3, 2025, Akos entered into two licensing agreements with Restoration Biologics LLC ('Restoration Biologics'), a biotechnology company focused on the treatment of joint disease.
Enveric Biosciences, Inc. Customers
Ticker
Name
Confidence
Evidence
MYCOMEDICA-LIFE-SCIENCES-PBC
MYCOMEDICA-LIFE-SCIENCES-PBC
92%
On November 7, 2024, the Company entered into an Out-Licensing Agreement with MycoMedica Life Sciences, PBC, a Delaware public benefit corporation ('MycoMedica'), pursuant to which the Company will o…
RESTORATION-BIOLOGICS-LLC
RESTORATION-BIOLOGICS-LLC
92%
The other patent family relates to cannabinoid conjugates in combination with COX-2 inhibitors for treatment of pain and joint disease, is licensed under two separate licenses for pharmaceutical and …
Enveric Biosciences, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
ENVB-DEBT
Debt stack $3.5M
90%
Market cache reports total debt of $3.5M.
ENVB-DEBT-9320
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2020-12-31.
ENVB-DEBT-9319
Warrants outstanding: 153060
90%
xbrl warrant detail from xbrl 2025-12-31.
Enveric Biosciences, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Enveric Biosciences, Inc..
Enveric Biosciences, Inc. Ownership
Holder
Name
Confidence
Evidence
ENVB-OWNER-CITIGROUP-INC
Citigroup Inc.
95%
13F/ownership overlay lists Citigroup Inc.; shares held 2,276; ownership 0.12%; value $4,142; as of 2025-12-31.
ENVB-OWNER-WELLS-FARGO-COMPANY
Wells Fargo & Company
95%
13F/ownership overlay lists Wells Fargo & Company; shares held 1; value $1; as of 2025-12-31.
ENVB-OWNER-BANK-OF-AMERICA-CORPORATION
Bank of America Corporation
95%
13F/ownership overlay lists Bank of America Corporation; shares held 5; value $9; as of 2025-12-31.
ENVB-OWNER-ADVISORSHARES-INVESTMENTS-LLC
AdvisorShares Investments, LLC
95%
13F/ownership overlay lists AdvisorShares Investments, LLC; shares held 16,974; ownership 0.90%; value $30,892; as of 2025-12-31.
ENVB-OWNER-BLACKROCK-INC
Blackrock Inc.
95%
13F/ownership overlay lists Blackrock Inc.; shares held 51; value $92; as of 2025-12-31.
ENVB-OWNER-SBI-SECURITIES-CO-LTD
SBI Securities Co., Ltd.
95%
13F/ownership overlay lists SBI Securities Co., Ltd.; shares held 49; value $89; as of 2025-12-31.
ENVB-OWNER-UBS-GROUP-AG
UBS Group AG
95%
13F/ownership overlay lists UBS Group AG; shares held 2,895; ownership 0.15%; value $5,268; as of 2025-12-31.
ENVB-OWNER-NATIONAL-BANK-OF-CANADA-FI
National Bank of Canada/FI/
95%
13F/ownership overlay lists National Bank of Canada/FI/; shares held 1; value $1; as of 2025-12-31.
ENVB-OWNER-DANSKE-BANK-A-S
Danske Bank A/s
95%
13F/ownership overlay lists Danske Bank A/s; shares held 1; value $1; as of 2025-12-31.
ENVB-OWNER-TOWER-RESEARCH-CAPITAL-LLC-TRC
Tower Research Capital LLC (TRC)
95%
13F/ownership overlay lists Tower Research Capital LLC (TRC); shares held 1,917; ownership 0.10%; value $3,488; as of 2025-12-31.
Enveric Biosciences, Inc. Extended Supply Chain Network
No secondary connectionsNo correlated companies found through shared supply chain relationships.
